Point tools give you data. BioAlma gives you decisions.
The Medical & Business intelligence platform for biotech — two functions, nine modules, one source of truth. Type a company name to see a live snapshot, free.
Nine modules. One login. One source of truth.
Medical Affairs and Business Development share one data model — a signal in one module updates the others, so every team works from the same continuously updated picture.
Synthesis is the product — BioAlma connects public, congress, client, and acquired data into one decision-ready view.
✨ Interactive
Synthesis is the product
BioAlma connects public, congress, client, and acquired data into one decision-ready view. Model competitive launches, market sizing, and risk on a visual canvas — every assumption structured, sourced, auditable, and ready for your board.
✓ Public, congress, client, and acquired data in one view
✓ Assumptions structured and traceable to sources
✓ Shareable canvases for board and partner prep
✓ What-if modeling with instant recalculation
Illustrative scenario
🗺️ Provider & Market Intelligence
Your market, mapped
See where the market actually is. KOLs, treatment sites, and infusion centers in one geographic view — with patient distributions, referral patterns, and account segmentation layered on the same map your field teams plan against.
✓ Infusion centers, treatment sites & KOLs on one US map
✓ Patient & claims distributions by geography
✓ Account segmentation and territory whitespace
✓ The same provider intelligence powering the dashboard
Built by someone who's been in your shoes
BioAlma is the intelligence platform, and Daniel Branco is its human operator: a neurologist and venture builder who builds your intelligence boards and stays on the other end to think them through with you.